Skip to content

Effect of tacrolymus on allergic conjunctivitis

Effect of tacrolymus on chronic allergic conjunctivitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201409248410N3
Enrollment
126
Registered
2014-10-08
Start date
2011-07-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic allergic conjunctivitis. chronic conjunctivitis

Interventions

Intervention 1: In control group patient will treat by Flucort Eye Drops every 6h and ketotifen eye drop every 12h and Dicloptin eye drop every 12h for 3 months. Intervention 2: In intervention group
Treatment - Drugs
In control group patient will treat by Flucort Eye Drops every 6h and ketotifen eye drop every 12h and Dicloptin eye drop every 12h for 3 months.
In intervention group in addition to standard treatment in control group, patient will use topical tacrolimus with low thickness on the back of eyelids every night until a week then every 12h until 3

Sponsors

Arak University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:1. Allergic conjunctivitis. Exclusion criteria:1.Blepharitis 2.Follicular blepharitis 3.Iritis 4.Eye infection 5.Evidence of herpes infection in the past

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Eye pruritus. Timepoint: every week until one month then every month until 3 months. Method of measurement: VAS criteria.;Eye Erythema. Timepoint: every week until one month then every month until 3 months. Method of measurement: slit lamp exam.;Foreign body sensation. Timepoint: every week until one month then every month until 3 months. Method of measurement: VAS criteria.

Secondary

MeasureTime frame
Eye pain. Timepoint: every week until one month then every month until 3 months. Method of measurement: VAS criteria.;Ptosis. Timepoint: every week until one month then every month until 3 months. Method of measurement: VAS criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr ahmad sarvarian

Arak university of medical sciences

dr.ahsarvarian@arakmu.ac.ir+98 863135075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026